Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in rheumatoid arthritis
June 10, 2015 at 08:02 AM EDT
Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced that five abstracts featuring data from three ...
